Merck Drn Ed Mb MRCK34 Income Statements

Conto economico

Quarter End	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024	Dic 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	14,49B	15,04B	15,96B	14,63B	15,78B	16,11B	16,66B	15,62B
Reddito operativo	3,74B	-5,17B	5,75B	-1,97B	5,64B	6,05B	3,93B	4,3B
Reddito ante imposte	3,65B	-5,34B	5,62B	-2,05B	5,67B	6,01B	4,09B	4,17B
Reddito netto	2,82B	-5,98B	4,75B	-1,23B	4,76B	5,46B	3,16B	3,74B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	3,4B	-4,97B	5,98B	-1,71B	5,84B	6,18B	4,43B	4,3B
EBITDA	4,73B	-4,26B	6,76B	-225M	6,62B	7,18B	5,11B	5,49B

Fine anno 31 Dicembre 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	40,12B	42,29B	46,84B	47,99B	48,7B	59,28B	60,12B	64,17B
Reddito operativo	6,58B	8,3B	11,6B	7,91B	12,54B	17,95B	2,36B	19,91B
Reddito ante imposte	6,52B	8,7B	11,46B	8,79B	13,88B	16,44B	1,89B	19,94B
Reddito netto	2,39B	6,22B	9,71B	7,07B	13,05B	14,52B	365M	17,12B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0.88	2.376	3.787	1.962	5.112	4.031	0.143	6.7
UTILE OPERATIVO	6,88B	8,95B	12,1B	8,37B	13,32B	18,95B	2,71B	20,75B
EBITDA	11,79B	12,75B	15,43B	13,25B	16,03B	23,6B	7,01B	24,41B